Study highlights how fluorescence imaging benefits cervical and...
In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer...
Improving B-cell lymphoma treatment with immunotherapies...
Lymphomas are the most common hematological malignancy in the U.S., accounting for an estimated 80,000 new cancer diagnoses and 21,000...
Nobel Week kicks off for immunotherapy innovator Jim Allison
As his first official act of Nobel Week, 2018 Nobel Laureate in Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the...
Be Well Baytown celebrates one year of making impact on community...
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is...
Clinical trials lead to FDA approval of two drugs for acute...
Researchers in MD Anderson’s Leukemia department played central roles in the studies of two drugs, glasdegib and venetoclax, approved...
Lung Cancer Moon Shot team is learning the most from...
Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United...
Minimally invasive delivery of radiation therapy to...
Pancreatic cancer is one of the most lethal types of cancer, expected to cause more than 44,000 deaths in the U.S. this year. It’s a...
Next-generation sequencing bolsters breast, prostate and...
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to...
More cervical cancer recurrence with minimally invasive surgery
Minimally invasive hysterectomies, which are known for shorter, less stressful recovery periods, are considered easier on patients....
ARTEMIS clinical trial offers triple-negative patients...
Triple-negative breast cancer (TNBC) makes up 15 to 20 percent of breast cancer diagnoses. The condition often is considered a single...
Possible side effects of immunotherapy — and how to handle...
Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma,...
Biomarker predicts response to pancreatic cancer therapy
MD Anderson researchers have discovered that a protein called angiogenin (ANG) serves as a potential biomarker useful for stratifying...
Potential biomarker linked to better outcomes in acute...
Somatic mutations in certain genes may function as a molecular minimal residual disease marker for acute myeloid leukemia (AML),...
Moon Shot update: Gaining ground on hard-to-treat blood...
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction...
Ovarian Moon Shot team battles highly recurrent disease
September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than...
Immunotherapy can fire up a protein that disables a T cell...
Lung cancer immunotherapy triggers a counterattack by a surface protein found on the tumors of some patients that stifles the immune...
Collaboration yields comprehensive CAR T-cell therapy pediatric...
Almost one year after the Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapy for children...
MD Anderson once again named No. 1 for cancer care
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
Communication skills may help keep research trainees on the...
A well-trained research workforce is essential for addressing both current and future health challenges in the U.S. However, according...
New venture will lead to new treatments for chemotherapy's...
MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have launched...
Uncovering an enemy of lung cancer immunotherapy
MD Anderson researchers have uncovered a genetic condition that thwarts the most common immunotherapy used against lung cancer,...
Basic science research could greatly improve cancer...
Many are aware of the importance of cancer research for the discovery of new therapies and treatment options, but perhaps less...
Drug prolongs survival for patients with deadly type of AML
A study led by MD Anderson found the investigational drug quizartinib prolongs overall survival for patients with a deadly form of...
Innovative study delivers genetic screening to your doorstep
When Elizabeth White started a new job as executive director of the Michigan Ovarian Cancer Alliance in 2017, she decided it...
Therapeutics Discovery drug impairs cancer cells’ growth...
A drug discovered and advanced by MD Anderson’s Institute for Applied Cancer Science (IACS) and the TRACTION platform inhibits a...
An update on the Prostate Cancer Moon Shot's efforts to...
Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the...
Using hypnosedation instead of general anesthesia during...
Most people think of hypnosis as a kind of party trick — a mischievous way to make somebody unconsciously do your bidding.
But...
Pioneering endogenous T-cell therapy for cancer treatments
Immunotherapy, which stimulates the patient’s own immune system to attack cancer, has shown promise in treating a variety of cancer...
MD Anderson faculty members awarded at ASCO Annual Meeting
For their role in transforming cancer care, three MD Anderson faculty received the American Society of Clinical Oncology’s Special...
Matching targeted therapies to gene mutations improves...
Matching targeted therapies to tumor-specific gene mutations across tumor types improved survival in patients with advanced cancer,...
Drug may benefit urinary tract cancer patients
In recent years, five new immunotherapy drugs have been approved to treat patients diagnosed with urinary cancer. But the drugs, which...
Could a pill replace chemotherapy for some patients?
In a small Phase II study of early-stage breast cancer patients with BRCA 1 and 2 mutations, researchers found that more than half of...
Researcher found a way to analyze the DNA of individual...
Understanding evolution within cancer cells is a longtime interest for Nicholas Navin, Ph.D., an associate professor of Genetics and...
PARP inhibitor shows benefit for small cell lung cancer...
In a randomized, Phase II trial led by researchers at MD Anderson, adding the PARP inhibitor veliparib to a standard chemotherapy...
8 researchers join ranks of Sabin Family Fellows
Eight MD Anderson researchers have been selected as the newest class of Andrew Sabin Family Fellows. As part of the Andrew Sabin...
Her discovery expanded our knowledge of cancer genetics
Shortly after arriving at MD Anderson in 1987 as a junior faculty member, Guillermina Lozano, Ph.D., attended several seminars hosted...
Partnerships to reduce young people’s exposure to UV...
Reducing the incidence of melanoma through primary and secondary prevention is among one of the shared goals and key partnership...
Training dermatologists to detect melanoma at its earliest...
Each May, Skin Cancer Awareness Month serves as a reminder of how individuals can work to lower their risk of skin cancer – the most...
Making re-irradiation an option for recurrent head and neck...
Patients with recurrent or second primary head and neck cancer who previously received radiation therapy to the head and neck region –...
Honing in on why triple-negative breast cancer can survive...
Triple-negative breast cancer (TNBC) is an aggressive form of the disease that doesn’t rely on the hormones estrogen and progesterone...
Quit-smoking toolkit targets residents of public housing
By July 31, all U.S. Department of Housing and Urban Development (HUD) housing will be required to be smokefree, in accordance to rule...
Vaccine exposes evasive colorectal cancer to an immune attack
Immunotherapy has taken hold as an effective treatment for a variety of advanced cancers, but so far, colorectal cancer has...
Immune helper cells appear to fuel pancreatic cancer...
Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that...
Improving practice to eliminate high risk and prevent...
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ...
Assets and obstacles in the fight to prevent HPV-related...
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the...
Immunotherapy, liquid biopsy research among AACR highlights
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting,...
Fidler honored for landmark findings on cancer metastasis
The American Association for Cancer Research (AACR) has selected Isaiah J. Fidler, D.V.M., Ph.D., professor of Cancer Biology, as...
Removing melanoma's cloak of immune invisibility
Melanoma cells are able to evade cancer immunotherapy by using a specific protein to hide from immune system T cells out to seek and...
Merging an MRI with a linear accelerator allows greater...
When people breathe, there’s movement inside their bodies.
Organs, tissues and even cancer patients’ tumors move around all the time...
MD Anderson's research, prevention and recruitment efforts...
MD Anderson was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30% of the...
Using integromics to better understand and treat colorectal...
MD Anderson’s Colorectal Cancer Moon Shot™ is committed to the prevention and early detection of the third most common cancer...
MD Anderson company to develop cell therapies for cancer
Cell-based immunotherapies such as chimeric antigen receptors (CAR T), T-cell receptor (TCR) engineered T cells, tumor-infiltrating...
Proton therapy may help breast cancer patients avoid...
Radiation therapy to the whole breast or chest wall and the internal mammary lymph nodes can deliver a radiation dose to the heart...
Obesity linked to longer survival in men with advanced...
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a...
Smart bomb virus shows promise as a brain tumor...
A cold virus engineered to attack the most common and deadly of brain tumors allowed 20% of patients with recurrent glioblastoma to...
Immunotherapy leader Jim Allison honored by BBVA and King...
Organizations in Spain and Saudi Arabia recognized the leadership of Jim Allison, Ph.D., MD Anderson chair of Immunology, in...
Targeted therapies before and after surgery delay melanoma...
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression...
Checkpoint blockade immunotherapy may potentially treat...
Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone disease that accounts for one-fourth of all breast cancers,...
New study evaluates need for biopsies after breast cancer...
In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from MD Anderson...
Small increase in medication may play a big part in helping...
Increasing the dosage of a prescription smoking cessation medication by 1 milligram a day – from 2 to 3 milligrams – more than doubled...
New developments in managing chemotherapy-induced neuropathy
Chemotherapy is a proven and effective method for treating many types of cancer, but up to 90% of patients who receive the treatment...
Do modern chemo drugs raise the risk of leukemia in some...
Older patients with non-metastatic breast cancer who have been treated modern chemotherapy drugs have a greater risk of secondary...
MD Anderson surgeons pioneer organ-sparing therapy for...
Until recently, patients with esophageal cancer were treated with esophagectomy, or removal of the affected part of the esophagus and...
Study sheds light on why some early-stage breast cancers...
A new genetic-based model developed by an MD Anderson research team may explain how a common form of early-stage breast cancer known...